期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Clinical outcomes of sacral neuromodulation in non-neurogenic,non-obstructive dysuria:A 5-year retrospective,multicentre study in China 被引量:1
1
作者 Ling-Feng Meng Wei Zhang +11 位作者 Jian-Ye Wang Yao-Guang Zhang Peng Zhang Li-Min Liao jian-wei lv Qing Ling Zhong-Qing Wei Tie Zhong Zhi-Hui Xu Wei Wen Jia-Yi Li De-Yi Luo 《World Journal of Clinical Cases》 SCIE 2020年第12期2494-2501,共8页
BACKGROUND Management of non-neurogenic,non-obstructive dysuria represents one of the most challenging dilemmas in urological practice.The main clinical symptom is the increase in residual urine.Voiding dysfunction is... BACKGROUND Management of non-neurogenic,non-obstructive dysuria represents one of the most challenging dilemmas in urological practice.The main clinical symptom is the increase in residual urine.Voiding dysfunction is the main cause of dysuria or urinary retention,mainly due to the decrease in bladder contraction(the decrease in contraction amplitude or duration)or the increase in outflow tract resistance.Sacral neuromodulation(SNM)has been used for>10 years to treat many kinds of lower urinary tract dysfunction.It has become increasingly popular in China in recent years.Consequently,studies focusing on nonneurogenic,non-obstructive dysuria patients treated by SNM are highly desirable.AIM To assess the outcome of two-stage SNM in non-neurogenic,non-obstructive dysuria.METHODS Clinical data of 54 patients(26 men,28 women)with non-neurogenic,nonobstructive dysuria treated by SNM from January 2012 to December 2016 in ten medical centers in China were retrospectively analyzed.All patients received two or more conservative treatments.The voiding diary,urgency score,and quality of life score before operation,after implantation of tined lead in stage I(test period),and during short-term follow-up(latest follow-up)after implantation of the implanted pulse generator in stage II were compared to observe symptom improvements.RESULTS Among the 54 study patients,eight refused to implant an implanted pulse generator because of the unsatisfactory effect,and 46 chose to embed the implanted pulse generator at the end of stage I.The conversion rate of stage I to stage II was 85.2%.The average follow-up time was 18.6 mo.There were significant differences between baseline(before stage I)and the test period(after stage I)in residual urine,voiding frequency,average voiding amount,maximum voiding amount,nocturia,urgency score,and quality of life score.The residual urine and urgency score between the test period and the latest follow-up time(after stage II)were also significantly different.No significant differences were observed for other parameters.No wound infection,electrode breakage,or other irreversible adverse events occurred.CONCLUSION SNM is effective for patients with non-neurogenic,non-obstructive dysuria showing a poor response to traditional treatment.The duration of continuous stimulation may be positively correlated with the improvement of residual urine. 展开更多
关键词 DYSURIA Implanted pulse generator Non-neurogenic NON-OBSTRUCTIVE Sacral neuromodulation
下载PDF
Exploration of Oxidative Ritter-Type Reaction ofα-Arylketones and Its Application for the Collective Total Syntheses of Erythrina Alkaloids
2
作者 Meng-En Chen Shi-Zhong Tang +4 位作者 Yue-Hong Hu Qin-Tong Li Zhang-Yan Gan jian-wei lv Fu-Min Zhang 《CCS Chemistry》 CAS 2022年第10期3378-3390,共13页
Although the classical Ritter reaction has beenwidely applied to prepare sterically hindered amides since 1948,it has intrinsic problems,such as harsh reaction conditions,the multistep preparation of synthetic precurs... Although the classical Ritter reaction has beenwidely applied to prepare sterically hindered amides since 1948,it has intrinsic problems,such as harsh reaction conditions,the multistep preparation of synthetic precursors,and the use of solvent quantities of nitrile.In particular,only a few examples of the total synthesis of natural products using the Ritter reaction as a key step have been reported to date. 展开更多
关键词 oxidative Ritter-type reaction sterically hindered amide erythrina alkaloids collective total syntheses protecting-group free procedure
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部